Singular Genomics | ARS:年度報告
Singular Genomics | DEF 14A:股東委託書決議
Singular Genomics | DEFA14A:其他
Singular Genomics | PRE 14A:並購重組委托聲明
Singular Genomics | 4:持股變動聲明-高管 Ropp Sam
Singular Genomics | 4:持股變動聲明-高管 Meeter Dalen
Singular Genomics | 4:持股變動聲明-高管 Glezer Eli N.
Singular Genomics | 4:持股變動聲明-高管 Spaventa Andrew
Singular Genomics | S-8:員工福利計劃證券登記
Singular Genomics | 10-K:年度報表
Singular Genomics | 8-K:Singular Genomics報告了近期亮點以及2023年第四季度和全年財務業績
Singular Genomics | SC 13G/A:超過5%持股股東披露文件(修正)-Eli Glezer(6.6%)
Singular Genomics | SC 13G/A:超過5%持股股東披露文件(修正)-Andrew Spaventa(7.9%)
Singular Genomics | 4:持股變動聲明-高管 Ropp Sam
Singular Genomics | 4:持股變動聲明-高管 Ghai Jyotsna
Singular Genomics | 4:持股變動聲明-高管 Meeter Dalen
Singular Genomics | 4:持股變動聲明-高管 Glezer Eli N.
Singular Genomics | 4:持股變動聲明-高管 Spaventa Andrew
Singular Genomics | SC 13G/A:超過5%持股股東披露文件(修正)-Deerfield Management Company, L.P.(6.83%),James E. Flynn(6.83%)等
Singular Genomics | SC 13G/A:超過5%持股股東披露文件(修正)-Domain Partners IX, L.P.(5.1%),Domain Associates, LLC(Less than 0.1%)
暫無數據